PL376399A1 - Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same - Google Patents

Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same

Info

Publication number
PL376399A1
PL376399A1 PL03376399A PL37639903A PL376399A1 PL 376399 A1 PL376399 A1 PL 376399A1 PL 03376399 A PL03376399 A PL 03376399A PL 37639903 A PL37639903 A PL 37639903A PL 376399 A1 PL376399 A1 PL 376399A1
Authority
PL
Poland
Prior art keywords
medicaments
production
same
pyridopyrimidinone compounds
pyridopyrimidinone
Prior art date
Application number
PL03376399A
Other languages
English (en)
Polish (pl)
Inventor
Sylvain Rault
Jean-Charles Lancelot
Marina Kopp
Daniel-Henri Caignard
Bruno Pfeiffer
Pierre Renard
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL376399A1 publication Critical patent/PL376399A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL03376399A 2002-11-05 2003-11-04 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same PL376399A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0213804A FR2846657B1 (fr) 2002-11-05 2002-11-05 Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PL376399A1 true PL376399A1 (en) 2005-12-27

Family

ID=32104442

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03376399A PL376399A1 (en) 2002-11-05 2003-11-04 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same

Country Status (28)

Country Link
US (1) US7361662B2 (uk)
EP (1) EP1560826B1 (uk)
JP (1) JP2006512317A (uk)
KR (1) KR100717489B1 (uk)
CN (1) CN1330650C (uk)
AR (1) AR041883A1 (uk)
AT (1) ATE323092T1 (uk)
AU (1) AU2003292320B2 (uk)
BR (1) BR0315801A (uk)
CA (1) CA2503995A1 (uk)
CY (1) CY1105047T1 (uk)
DE (1) DE60304599T2 (uk)
DK (1) DK1560826T3 (uk)
EA (1) EA009043B1 (uk)
ES (1) ES2261978T3 (uk)
FR (1) FR2846657B1 (uk)
GE (1) GEP20084376B (uk)
HK (1) HK1081965A1 (uk)
MA (1) MA27410A1 (uk)
MX (1) MXPA05004789A (uk)
MY (1) MY140164A (uk)
NO (1) NO20052683L (uk)
NZ (1) NZ539598A (uk)
PL (1) PL376399A1 (uk)
PT (1) PT1560826E (uk)
UA (1) UA80578C2 (uk)
WO (1) WO2004043956A1 (uk)
ZA (1) ZA200503233B (uk)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2079739A2 (en) * 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
CN101619063B (zh) * 2009-06-02 2011-08-10 华中师范大学 具有抗肿瘤活性的3,7,8-多取代吡啶并[4,3-d]嘧啶衍生物及制备
WO2011012883A1 (en) * 2009-07-29 2011-02-03 Karus Therapeutics Limited Benzo [e] [1, 3 ] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
ES2534326T3 (es) 2009-08-20 2015-04-21 Karus Therapeutics Limited Compuestos tricíclicos heterocíclicos como inhibidores de la fosfoinositida 3-cinasa
GB201204125D0 (en) 2012-03-08 2012-04-25 Karus Therapeutics Ltd Compounds
MX2015004016A (es) 2012-09-28 2016-02-18 Ignyta Inc Inhibidores de azaquinazolina de la proteina quinasa c atipica.
GB201402431D0 (en) 2014-02-12 2014-03-26 Karus Therapeutics Ltd Compounds
AU2015340215B2 (en) 2014-10-29 2018-11-15 Dong-A St Co., Ltd Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (KDMs)
GB201514754D0 (en) 2015-08-19 2015-09-30 Karus Therapeutics Ltd Compounds
GB201514760D0 (en) * 2015-08-19 2015-09-30 Karus Therapeutics Ltd Compounds and method of use
GB201514758D0 (en) 2015-08-19 2015-09-30 Karus Therapeutics Ltd Formulation
GB201514751D0 (en) 2015-08-19 2015-09-30 Karus Therapeutics Ltd Compounds
US20170057955A1 (en) * 2015-08-26 2017-03-02 Dong-A Socio Holdings Co., Ltd. Pyridopyrimidinone Compounds for Modulating the Catalytic Activity of Histone Lysine Demethylases (KDMs)
CN105616420A (zh) * 2016-01-16 2016-06-01 赵国良 一种降血脂的药物组合物
SI3762368T1 (sl) 2018-03-08 2022-06-30 Incyte Corporation Aminopirazin diolne spojine kot zaviralci PI3K-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
CA3162236A1 (en) * 2019-11-22 2021-05-27 Senda Biosciences, Inc. Pyridopyrimidinone derivatives as ahr antagonists
WO2024008722A2 (en) * 2022-07-04 2024-01-11 Muna Therapeutics Aps Trem2 modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348310B1 (en) * 1994-03-04 2002-02-19 Promega Corporation Quantitation of individual protein kinase activity
US6060477A (en) * 1995-06-07 2000-05-09 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
ZA9756B (en) * 1996-01-16 1997-07-17 Warner Lambert Co Process for preparing 4,6-disubstituted pyrido[3,4-d]-pyrimidines
HRP970371A2 (en) * 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
BR9710808A (pt) * 1996-08-06 1999-08-17 Pfizer Derivados biciclicos 6,6 ou 6,7 contendo pirito ou pirimido substitu¡dos
US6962922B2 (en) * 2001-10-12 2005-11-08 Warner-Lambert Company Llc Alkynylated quinazoline compounds
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds

Also Published As

Publication number Publication date
PT1560826E (pt) 2006-07-31
NO20052683D0 (no) 2005-06-03
EP1560826B1 (fr) 2006-04-12
AU2003292320B2 (en) 2009-03-12
WO2004043956A8 (fr) 2005-06-09
UA80578C2 (en) 2007-10-10
GEP20084376B (en) 2008-05-27
US20050288311A1 (en) 2005-12-29
DE60304599T2 (de) 2007-05-16
FR2846657A1 (fr) 2004-05-07
MY140164A (en) 2009-11-30
NO20052683L (no) 2005-06-03
BR0315801A (pt) 2005-09-20
EP1560826A1 (fr) 2005-08-10
EA009043B1 (ru) 2007-10-26
JP2006512317A (ja) 2006-04-13
KR100717489B1 (ko) 2007-05-14
CA2503995A1 (fr) 2004-05-27
AR041883A1 (es) 2005-06-01
CN1330650C (zh) 2007-08-08
NZ539598A (en) 2006-11-30
ATE323092T1 (de) 2006-04-15
DK1560826T3 (da) 2006-08-14
CN1711260A (zh) 2005-12-21
US7361662B2 (en) 2008-04-22
DE60304599D1 (de) 2006-05-24
ES2261978T3 (es) 2006-11-16
HK1081965A1 (en) 2006-05-26
FR2846657B1 (fr) 2004-12-24
WO2004043956A1 (fr) 2004-05-27
AU2003292320A1 (en) 2004-06-03
KR20050087792A (ko) 2005-08-31
MA27410A1 (fr) 2005-06-01
ZA200503233B (en) 2006-06-28
CY1105047T1 (el) 2009-11-04
EA200500690A1 (ru) 2005-10-27
MXPA05004789A (es) 2005-07-22

Similar Documents

Publication Publication Date Title
HK1081965A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
ZA200500086B (en) Novel carboxamide compounds having an MCH-antagonistic effect, medicaments containing said compounds, and method for the production thereof
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
HUP0401293A3 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
AU2003257465A1 (en) Substituted diaryl heterocycles, method for the production and use thereof as medicaments
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
HRP20040930A2 (en) Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
AU2003266194A8 (en) Nanocomposite, method for production and use thereof
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
ZA200409381B (en) Ring-substituted diphenyl azetidones, method for the production thereof, medicaments containing said compounds, and use thereof
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
HK1075650A1 (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
ZA200500526B (en) Prodrug, medicinal utilization thereof and process for producing the same
AU2003226806A1 (en) Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
EP1537083A4 (en) S - (-) - AMLODIPINNICOTINATE AND METHOD FOR THE PRODUCTION THEREOF
IL174975A0 (en) 2-phenyl-benzofuran derivatives, method for the production thereof and their use
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
EP1489087A4 (en) BISPHOSPHIN, METHOD FOR THE PRODUCTION THEREOF AND ITS USE
SI1560826T1 (sl) Spojine piridopirimidinona, postopek za njihovo pripravo in farmacevtski sestavki, ki te vsebujejo

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)